BioPharma SHAKTI aims to revolutionize biologics by promoting non-animal models for safer and more effective drug development.

Our body's "blood factory" consists of specialized tissue made up of bone cells, blood vessels, nerves and other cell types. Now, researchers have succeeded for the first time in recreating this ...

As non-animal models move mainstream, the focus is shifting toward reproducibility and data integrity. By using specialized ...

Using mathematical analysis of patterns of human and animal cell behavior, scientists say they have developed a computer program that mimics the behavior of such cells in any part of the body. Led by ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...

Scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina. The findings in animals may help advance treatment options for dry age-related macular ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

Every multicellular organism, from tiny worms to humans, elephants, and whales, needs a way for their cells to connect with ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...